SCHEMBL2535153

SCHEMBL2535153

CCCCCCC(C(=O)OCC)C(CO)C(=O)OCC

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.45
ZDHHC7 Q9NXF8 1/20 0.44
GPR84 Q9NQS5 4/20 0.41
FFAR1 O14842 1/20 0.41
KDM4E B2RXH2 1/20 0.41
DUSP3 P51452 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
MAPT P10636 2/20 0.41
MAPK1 P28482 1/20 0.41
CPB2 Q96IY4 1/20 0.40
LCK P06239 1/20 0.40
PPARD Q03181 1/20 0.40
ZDHHC20 Q5W0Z9 1/20 0.40
ZDHHC2 Q9UIJ5 1/20 0.40
PRKCA P17252 1/20 0.39
PRKCE Q02156 1/20 0.39
PRKCQ Q04759 1/20 0.39
PRKCD Q05655 1/20 0.39
FAAH O00519 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7070785 0.92 ZDHHC7 (0.50) ZDHHC7GPR84FFAR1MAPTCPB2
SCHEMBL19690704 0.92 ZDHHC7 (0.50) ZDHHC7GPR84FFAR1MAPTCPB2
SCHEMBL13269368 0.90 ZDHHC7 (0.47) ZDHHC7GPR84FFAR1MAPTCPB2
SCHEMBL27958014 0.85 GPR84 (0.50) ZDHHC7GPR84FFAR1MAPTCPB2
SCHEMBL234311 0.84 CA2 (0.47) LMNAZDHHC7KMT2AMAPK1CPB2
SCHEMBL492798 0.84 ZDHHC7 (0.43) ZDHHC7GPR84FFAR1MAPTCPB2
SCHEMBL17713606 0.83 ZDHHC7 (0.46) ZDHHC7GPR84FFAR1MAPTCPB2
SCHEMBL2803737 0.81 ZDHHC7 (0.44) ZDHHC7GPR84FFAR1MAPTCPB2
SCHEMBL2249063 0.81 FAAH (0.46) ZDHHC7GPR84FFAR1MAPTFAAH
SCHEMBL29186605 0.81 GPR84 (0.46) LMNAZDHHC7GPR84FFAR1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8044068-B2 Aminopyrrolidine compound TAISHO PHARMACEUTICAL CO., LTD (JP) 2011-10-25 US disclosed
US-20090291940-A1 AMINOPYRROLIDINE COMPOUND TAISHO PHARMACEUTICAL CO., LTD. (JP) 2009-11-26 US disclosed
EP-2003131-A1 AMINOPYRROLIDINE COMPOUND Taisho Pharmaceutical Co. Ltd. (JP) 2008-12-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090291940-A1 AMINOPYRROLIDINE COMPOUND MC4R, MC5R, MC2R LMNA 4408/4885ZDHHC7 4750/4885GPR84 112/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.